Author - David Miller

Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping...

More than a year has passed since Dana-Farber Cancer Institute dumped Mass General Brigham for a...

Sen. Elizabeth Warren (D-Mass.) is urging the Federal Trade Commission to scrutinize recent deals...

A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the...

This close to Nov. 5, we are being battered with promises that this race will determine the future...

With the rallying cry of corporate greed, each year of the Biden-Harris administration has brought...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark...

Health tech investments are showing signs of resilience following the perilous lows of 2022 and...

LONDON — GSK’s once booming vaccines business met new challenges in the third quarter, as the...